Live from the NIH registry
Studies recruiting near Hagerstown right now
Top 25 of 107 recruiting studies, sorted by proximity — each links to its official registry page
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
Klein and Associates — Hagerstown, Maryland (0.1 mi)
· Sponsor: Novartis Pharmaceuticals
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: NRG Oncology
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Psoriatic Arthritis
Phase 3
Interventional 1,182 participants sought
Klein and Associates, M.D., P.A. — Hagerstown, Maryland (0.1 mi)
· Sponsor: Takeda
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Breast Cancer
N/A
Observational 1,800 participants sought
Meritus Center for Clinical Research — Hagerstown, Maryland (0.1 mi)
· Sponsor: Exact Sciences Corporation
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
Macular Telangiectasia Type 2 (MacTel)
Phase 4
Interventional 234 participants sought
Cumberland Valley Retina Consultants — Frederick, Maryland (22.8 mi)
· Sponsor: Neurotech Pharmaceuticals
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Cumberland Valley Retina Consultants (Site 007) — Hagerstown, Maryland (0.1 mi)
· Sponsor: EyeBiotech Ltd.
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Neovascular Age-related Macular Degeneration, nAMD
Phase 3
Interventional 304 participants sought
Mid Atlantic Retina Specialists — Hagerstown, Maryland (0.1 mi)
· Sponsor: Amgen
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: Novo Nordisk A/S
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
Phase 3
Interventional 621 participants sought
Frederick Health Hospital- James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi)
· Sponsor: BioNTech SE
An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
Stomatitis
Phase 4
Interventional 100 participants sought
Research Site — Frederick, Maryland (22.8 mi)
· Sponsor: AstraZeneca
Molecular Genetics Studies of Cancer Patients and Their Relatives
Malignant Neoplasm
N/A
Observational 999,999 participants sought
Frederick Oncology Hematology Associates — Frederick, Maryland (22.8 mi)
· Sponsor: City of Hope Medical Center
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Pancreatic Neoplasm
N/A
Observational 770 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
FMH James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: NRG Oncology
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Phase 3
Interventional 700 participants sought
Frederick Health Hospital - James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi)
· Sponsor: Janssen Research & Development, LLC
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Mid Atlantic Retina Specialists — Hagerstown, Maryland (0.1 mi)
· Sponsor: EyeBiotech Ltd.
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Phase 2
Interventional 461 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: National Cancer Institute (NCI)
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: NRG Oncology
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: DalCor Pharmaceuticals
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Phase 3
Interventional 975 participants sought
Cumberland Valley Retina Consultants-Ophthalmology — Hagerstown, Maryland (0.1 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study in Adults With Geographic Atrophy
Geographic Atrophy
Phase 2
Interventional 300 participants sought
Cumberland Valley Retina Consultants,P.C. — Hagerstown, Maryland (0.1 mi)
· Sponsor: Sitala Bio LTD
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
Diabetic Macular Edema (DME)
Phase 3
Interventional 910 participants sought
Kodiak Research Center — Hagerstown, Maryland (0.1 mi)
· Sponsor: Kodiak Sciences Inc
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Lung Non-Small Cell Carcinoma
Phase 2
Interventional 88 participants sought
WellSpan Medical Oncology and Hematology — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: SWOG Cancer Research Network
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: NRG Oncology